There are many alternative ways of estimating free thyroxine (T4) when thyrotropin screening results are abnormal. In addition to free 14 immunoassays, the menu of most automated immunoassay instruments includes a nonisotopic version of the original triiodothyronine (Ta)-uptake assay called "T-uptake." We evaluated the ability of five such assays (Access, ES-300, IMx, Magnum Opus, and Stratus) to accurately estimate the free thyroxine index (FTI) in euthyroid, hyperthyroid, and hypothyroid patients with abnormal concentrations of thyroid hormone-binding proteins, and in patients with nonthyroidal illness. For comparison, we calculated a similar FTI, using either T3-uptake or direct measurement of thyroxine-binding globulin (TBG). Euthyroid reference ranges were comparable. Of euthyroid patients with increased TBG, 12-32% and 5-20% had increased or suppressed FTI, respectively, depending on the 1-uptake method used. approaches to free T4 measurement were developed (5). These became widely available, but their analytical performance is viewed with suspicion and, at least in the US, the use of the traditional FTI has continued. Recently, a new equilibrium dialysis method, in which dialysate T4 is directly measured, has been developed and is viewed as the most reliable direct measurement of free T4 (6). However, it is not likely to be widely used for routine clinical laboratory testing because it cannot be automated and still includes a radioactive label.
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Most new automated immunoassay instruments introduced into the clinical laboratory market have a sensitive TSH method and an immunoassay for free T4. However, because of continued interest in the traditional FTI, most also include an automated nonisotopic version of the original T,U assay. These have formats different from the original assay and, because they use labeled T4 rather than T,, have been termed "T-uptake" assays.
Although nonisotopic free T4 immunoassays have been extensively examined, relatively little attention has been paid in the literature to the analytical and clinical performance of these newly introduced T-uptake assays.We have evaluated the ability of five such assays to accurately estimate the FTI in euthyroid, hyperthyroid, and hypothyroid patients with abnormal concentrations of TBG and in patients with nonthyroidal illness.
We also examined their susceptibility to interference by free fatty acids and drugs known to affect the binding ofT4 by serum proteins. For comparison, we calculated FTI by using either a traditional manual radioactive T3U assay or a T4/TBG ratio.
Materials and Methods T-Uptake Assays
The automated nonisotopic methods we studied were the AccessThyroid Uptake (Sanofi Diagnostics Pasteur, Chaska Other Assays T,U was determined by using Tri To study the effects of free fatty acids and drugs known to interfere with the binding of T4 by serum proteins, we pooled aliquots from the euthyroid control specimens. Oleic acid (cis-9-octadecenoic acid, -99% pure), furosemide, flufenamic acid, and aspirin [acetylsalicylic acid (ASA)} were obtained from Sigma Chemical Co. (St. Louis, MO) and dissolved and diluted in absolute ethanol to achieve the desired final concentrations for adding 10 tL of each to 3.0-mL aliquots of the normal serum pool. We added 10 tL of absolute ethanol alone to one aliquot as a control specimen. These specimens were vortex-mixed briefly, incubated for 60 mm in a 37#{176}C water bath, and assayed for TBG, T3U, and T-uptake.
Results
Reference ranges for the three major thyroid hormone binding proteins (TBG, TTR, and albumin), T3U, and the five automated T-uptake assays were determined from the 40 normal volunteers' and the 40 euthyroid patients' samples. To express results as thyroid hormone-binding ratio (THBR), we divided individual uptake results by the mean observed in this reference population. This approach has been recommended by the American Thyroid Association as a way to standardize uptakes determined by different methodologies (11) . FF1 was determined by multiplying the total T4 by the THBR. This same approach was taken to estimate the T41TBG ratio, using the mean TBG value to normalize the individual TBG result, creating a similar THBR. In this way, each FTI can be directly compared, regardless of how it was determined. Reference ranges for FTI were comparable, regardless of the method used (Table 1) .
In euthyroid patients with increased TBG (Fig. 1) (Fig. 2) . If the TBG concentration was normal, the FTI was appropriately either low or high in most cases (Fig. 2a) . However, if the TBG was increased (Fig. 2b) , the FTI tended to be within the euthyroid reference range, even in patients with comparable TSH abnormalities. There was no significant difference in the mean FTI observed in patients with or without clinical evidence of thyroid disease (data not shown). Except for T4ITBG ratio, no hyperthyroid patients had low FTI. Most of the patients with nonthyroidal illness had either normal or decreased FTI, regardless of the method used (Fig. 3) . Alterations in thyroid-function tests in severely ill patients are poorly understood. Because circulating inhibitors of T4 binding, including nonesterifled or free fatty acids and various drugs, have been implicated (7, 12, 13), we studied the effects of these on the different uptake methods (Fig. 4) 
ES-300, but increased the T-uptake results with the Magnum,
Access, and Stratus. ASA, which interferes with all of the thyroid hormone-binding proteins (13), had no effect on Access, ES-300 or IMx, and only a slight effect on the Magnum and Stratus methods. The traditional T3U was affected significantly by furosemide, slightly by oleic acid and ASA, and not at all by flufenamic acid. As expected, the direct measurement of TBG was unaffected by any of the inhibitors.
All 15 specimens from patients with FDH and the one specimen containing TTR with increased affinity for T4 showed an increased FF1 with all of the assays except one. FTI calculated with the Access T-uptake was normal in 10 FDH patients (data not shown).
We used simple linear regression for analysis of the relations between the different T-uptake methods and the different binding proteins in the 247 patients' specimens. All of the T-uptake methods produced slopes significantly different from zero with TBG, TTR, and albumin. The correlation was significant, however, only with TBG. The results of the regression analyses appear in Table 2 
Discussion
In 1954, Hamoisky and Freedberg observed increased incorporation by rat diaphragm of radiolabeled T4 and T3 added to hyperthyroid plasma compared with that for euthyroid controls (16). Subsequently, they added radiolabeled T3 to whole-blood specimens and showed that incorporation of radioactivity into endogenousred blood cells was increased in hyperthyroidism and decreased in hypothyroidism (17) . This became known as the T3-uptake test, and was the first indirect estimation of serum thyroid hormone-binding In 1964, Clark and Horn introduced the use of the mathematical product of the total T4 (originally proteinbound iodine) and the T3U to estimate the free T4 concentration (27) (29) (30) (31) (32) . Another method of calculating FTI, by using the T/FBG ratio, was introduced in the 1970s (3, (33) (34) (35) but was never widely adopted because the original assays for TBG were more difficult to perform and more costly than T3U methods, and because the T4ITBG ratio was reported to be unreliable when TBG concentrations are extremely high or low (36) (37) (38) (39) . (47) and by direct free T4 immunoassay (48) .
Although the manufacturers of the IMx claim that this assay measures all of the thyroid hormone-binding proteins (49) , the only significant correlation in our study was with TBG concentration. By regression analysis, FTI results with the IMx T-uptake correlated best with those involving the T4ITBG ratio (data not shown). Since most assayscontinue to use barbital buffer, which prevents binding of thyroid hormone to TTR (50) , and since albumin cannot compete with TBG for thyroid hormone, T-uptake methods should continue to be con- Despite somerecent evaluations of automated nonisotopic free T4 immunoassays showing good clinical performance (51) , automated assays to measure thyroid hormone-binding proteins will probably continue to be an alternative. In its guidelines for the use of laboratory tests in thyroid disease, the American Thyroid Association makes no particular recommendation as to how free T4 concentrations should be estimated, and suggests that all methods have both advantages and pitfalls (52) . With increased interest in automated immunoassay systems, laboratories should choose one with both a sensitive TSH assay and a reliable way to estimate free T4. If calculation of FTI is considered desirable, the T-uptake method used should correlate well with the TBG concentration. 
